ESC Pocket Guidelines vs Lipid Manager

The ESC Pocket Guidelines app now contains the following ESC Pocket Guidelines: ESC Guidelines and documents published in 2025 Cardiovascular disease and pregnancy (Guidelines) Mental health and cardiovascular disease (Consensus Statement) Myocarditis and pericarditis (Guidelines) Valvular heart disease (Joint Guidelines with EACTS) Focused update of the 2019 dyslipidaemias guidelines ESC Guidelines published in 2024 Elevated blood pressure and hypertension Atrial fibrillation Chronic coronary syndromes Peripheral arterial and aortic diseases ESC Guidelines and documents published in 2023 Acute coronary syndromes Cardiomyopathies Cardiovascular disease in diabetes Endocarditis Focused update of the 2021 heart failure guidelines The ESC Pocket Guidelines app also contains interactive tools in the form of algorithms. Additional features: Perform „full text", „index" or „filtered" searches through the entire downloaded content of the app, bookmarks and the notes. Bookmark specific sections or create a personal note and access bookmarks and notes from the „Library“ section. Share links to specific areas of the app via communication channels, e.g. AirDrop, Mail, LinkedIn, Twitter, WhatsApp, and many others. Print pages. Please follow the link below to register for a new MyESC account: https://escol.escardio.org/MyESC/login.aspx

The ACC Lipid Manager app provides two clinical decision support tools in one app to help clinicians manage a patient’s triglycerides and LDL-C from therapy initiation through treatment calibration with the goal of lowering ASCVD risk: •  Lipid Lowering Therapy tool: Supports selection of lipid‑lowering therapies and individualized goals to reduce ASCVD risk through targeted management of LDL-C and triglycerides (previously known as LDL-C Lowering Therapy) •  Statin Intolerance tool: Evaluate the patient for possible statin intolerance, and determine appropriate next steps The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgement. Therapeutic options should be determined after discussion between the patient and their care provider. Financial support for Lipid Manager was provided by Esperion. All content was independently developed with no sponsor involvement.